Last reviewed · How we verify
NCT06274177
Evaluation of the BTL-785F Device for Submental Fat Reduction and Neck Rejuvenation
NA trial testing BTL-785-7 in Fat Burn in 37 participants. Completed in 12 September 2024.
4 August 2024
Quick facts
| Lead sponsor | BTL Industries Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 37 |
| Start date | 26 July 2023 |
| Primary completion | 4 August 2024 |
| Estimated completion | 12 September 2024 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- BTL-785-7
Conditions studied
- Fat Burn — all drugs for Fat Burn →
Sponsor
BTL Industries Ltd. — full company profile →
Who can join
21 and older, any sex, with Fat Burn. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate the clinical safety and the performance of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive reduction of submental fat and skin laxity treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
High-Intensity Focused Electrical Stimulation and Sync Radiofrequency+ Technology for Submental Volume Reduction: An MRI Study.
DiBernardo B, Jacob C, Clark-Loeser L. · · 2025 · PMID 40179240 · DOI 10.1093/asj/sjaf048
Verify or expand the search:
- PubMed search for NCT06274177
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of BTL-785-7
Trials testing the same drug.
- NCT05831332 — Safety and Efficacy of the BTL-785F Device for Non-invasive Reduction of Submental Fat · NA · completed
- NCT05524779 — BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement · NA · completed
- NCT05524740 — BTL-785F Device for Improving the Structure of Facial Muscles · NA · completed
- NCT05524662 — Clinical and Histological Evaluation of BTL-785F Device for Non-invasive Treatment of Face · NA · completed
- NCT05525026 — Evaluation of Safety and Efficacy of the BTL-785F Device for Non-invasive Facial Remodeling · NA · completed
Other recruiting trials for Fat Burn
Currently open trials in the same condition.
- NCT06763562 — Food Orders on Blood Glucose and Fuel Use At Rest · NA · recruiting
Other BTL Industries Ltd. trials
Trials by the same sponsor.
- NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
- NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
- NCT07179224 — EEG Changes After rTMS Stimulation · NA · completed
- NCT07024550 — Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway · NA · active not recruiting
- NCT07027657 — EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06274177 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by BTL Industries Ltd.
- Last refreshed: 16 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06274177.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing